Papers
1
Total Citations
21
H-Index
1
About
E. Eriks is a leading figure in radiochemistry and molecular imaging, with a primary focus on the development of novel positron emission tomography (PET) tracers for oncology. Their most cited work, "Development of a reliable remote‐controlled synthesis of β‐[¹¹C]‐5‐hydroxy‐L‐tryptophan on a Zymark robotic system" (2006, 21 citations), represents a landmark contribution to the field. This paper details a robust, automated method for producing a key tracer used in the precise staging of neuroendocrine tumors (NETs), enabling the visualization of specific metabolic activity that is critical for accurate diagnosis and treatment planning. By overcoming the challenges of synthesizing carbon-11 labeled 5-hydroxytryptophan (5-HTP), Eriks provided the radiochemistry community with a reproducible and scalable protocol, directly impacting clinical PET imaging. This work has been instrumental in advancing the use of metabolic tracers beyond the more common [¹⁸F]FDOPA, offering clinicians a powerful alternative for NET staging. Eriks's contributions exemplify the vital bridge between complex radiochemical synthesis and practical clinical application, earning them recognition as a key innovator in the development of next-generation imaging agents.
Research Focus
Key Achievements
Top Papers
- 1